Dr. Dexeus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 E Owen K Garriott Rd
Enid, OK 73701Phone+1 580-234-1061Fax+1 580-234-4058
Education & Training
Autonomous University of Barcelona Faculty of MedicineClass of 1974
Certifications & Licensure
CA State Medical License 1991 - 2026
NV State Medical License 1993 - 2025
OK State Medical License 1994 - 2025
TX State Medical License 1983 - 2025
WA State Medical License 2018 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 451 citationsA prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.Christopher J. Logothetis, Francisco H. Dexeus, Laury Finn, Avishay Sella, Robert J. Amato
Journal of Clinical Oncology. 1990-06-01 - 61 citationsCyclophosphamide, Doxorubicin and Cisplatin Chemotherapy for Patients with Locally Advanced Urothelial Tumors with or without Nodal MetastasesChristopher J. Logothetis, Melvin L. Samuels, Sheryl Ogden, Francisco H. Dexeus, David A. Swanson
The Journal of Urology. 1985-09-01 - 119 citationsChemotherapy for Small Cell Carcinoma of Prostatic OriginRobert J. Amato, Christopher J. Logothetis, Rebecca Hallinan, Jae Y. Ro, Avishay Sella
The Journal of Urology. 1992-03-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
